20-44724974-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003881.4(CCN5):c.514C>A(p.Gln172Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000014 in 1,432,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003881.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCN5 | NM_003881.4 | c.514C>A | p.Gln172Lys | missense_variant | 3/4 | ENST00000190983.5 | NP_003872.1 | |
KCNK15-AS1 | NR_132377.1 | n.439-8181G>T | intron_variant, non_coding_transcript_variant | |||||
CCN5 | NM_001323370.2 | c.514C>A | p.Gln172Lys | missense_variant | 4/5 | NP_001310299.1 | ||
CCN5 | NM_001323369.2 | c.286-2113C>A | intron_variant | NP_001310298.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCN5 | ENST00000190983.5 | c.514C>A | p.Gln172Lys | missense_variant | 3/4 | 1 | NM_003881.4 | ENSP00000190983 | P1 | |
KCNK15-AS1 | ENST00000445420.5 | n.146+13846G>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1432930Hom.: 0 Cov.: 30 AF XY: 0.00000141 AC XY: 1AN XY: 709632
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2023 | The c.514C>A (p.Q172K) alteration is located in exon 3 (coding exon 3) of the WISP2 gene. This alteration results from a C to A substitution at nucleotide position 514, causing the glutamine (Q) at amino acid position 172 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at